Ncpc Hebei Huamin Pharmaceutical Co. Ltd.
As of 18 November 2026, for the company name Ncpc Hebei Huamin Pharmaceutical Co. Ltd. as recorded, the chemical-drug catalogue lists 27 active records with this name as holder; 36 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
22 acceptance records as first applicant, grouped into 13 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
注射用头孢哌酮钠舒巴坦钠(2:1) · No verified English name 2 records · Latest accepted 2026/01/21
Supplement · 2
头孢呋辛酯干混悬剂 · No verified English name 2 records · Latest accepted 2026/01/16
Generic · 2
Cefprozil Tablets 1 records · Latest accepted 2024/10/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403463 | Generic | 2024/10/15 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
Cefuroxime Sodium for Injection 2 records · Latest accepted 2024/04/12
Supplement · 2
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2024/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400114 | Generic | 2024/01/09 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
Ceftriaxone Sodium for Injection 1 records · Latest accepted 2023/11/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302596 | Supplement | 2023/11/24 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
注射用头孢唑肟钠 · No verified English name 2 records · Latest accepted 2023/10/28
Supplement · 2
Cefoperazone Sodium and Sulbactam Sodium for Injection 2 records · Latest accepted 2023/09/13
Supplement · 2
注射用盐酸头孢吡肟 · No verified English name 2 records · Latest accepted 2023/06/30
Supplement · 2
Ceftazidime for Injection 2 records · Latest accepted 2023/01/12
Supplement · 2
头孢拉定胶囊 · No verified English name 1 records · Latest accepted 2022/09/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250549 | Supplement | 2022/09/01 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
Cefaclor Capsules 1 records · Latest accepted 2021/06/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150660 | Supplement | 2021/06/10 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
Cefotaxime Sodium For Injection 3 records · Latest accepted 2021/04/16
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150542 | Supplement | 2021/04/16 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| CYHB2150541 | Supplement | 2021/04/16 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| CYHB2150540 | Supplement | 2021/04/16 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 注射用头孢哌酮钠舒巴坦钠(2:1) · No verified English name | CYHB2650017 | Supplement | 2026/01/21 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢哌酮钠舒巴坦钠(2:1) · No verified English name | CYHB2650016 | Supplement | 2026/01/21 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | CYHS2600200 | Generic | 2026/01/16 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 头孢呋辛酯干混悬剂 · No verified English name | CYHS2600199 | Generic | 2026/01/16 | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
Catalogue holder records
27 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Cefprozil Tablets | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20263349 | 2026/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ceftazidime And Avibactam Sodium For Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20254420 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefuroxime Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20031237 | 2025/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefuroxime Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20060623 | 2025/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20083028 | 2024/11/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20041254 | 2024/11/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20184098 | 2024/10/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20193307 | 2024/10/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用盐酸头孢吡肟 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20050583 | 2024/07/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 注射用盐酸头孢吡肟 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20050582 | 2024/07/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20064583 | 2024/02/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20064584 | 2024/02/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢拉定胶囊 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H13020525 | 2023/09/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefaclor Capsules | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20073704 | 2022/10/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H13020665 | 2022/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20023681 | 2022/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H13020666 | 2022/03/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefalexin Tablets | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H13020526 | 2022/03/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢克肟颗粒 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20223124 | 2022/03/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoxitin Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20056973 | 2022/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20103686 | 2022/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20033242 | 2021/11/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20033235 | 2021/11/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20054715 | 2021/06/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20054510 | 2021/06/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢克肟胶囊 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H20080627 | 2021/05/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefalexin Capsules | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | 国药准字H13020524 | 2019/11/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
36 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 头孢托仑匹酯 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20240000528 | A | 2026/02/26 | CDE ↗ |
| 头孢丙烯 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20240000428 | A | 2025/12/09 | CDE ↗ |
| 头孢羟氨苄 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190009579 | A | 2025/02/15 | CDE ↗ |
| 头孢西丁钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190008845 | A | 2025/09/02 | CDE ↗ |
| 头孢他啶 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190007946 | A | 2025/03/20 | CDE ↗ |
| 头孢他啶 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190007945 | A | 2025/03/28 | CDE ↗ |
| 盐酸头孢吡肟 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190007235 | A | 2023/05/17 | CDE ↗ |
| 头孢硫脒 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190006283 | A | 2025/03/20 | CDE ↗ |
| 头孢米诺钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190005035 | A | 2025/06/07 | CDE ↗ |
| 硫酸头孢匹罗 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190005034 | A | 2025/11/09 | CDE ↗ |
| 头孢尼西钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190005027 | A | 2025/03/28 | CDE ↗ |
| 头孢孟多酯钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190005026 | A | 2025/03/28 | CDE ↗ |
| 奥扎格雷 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190005024 | A | 2025/02/15 | CDE ↗ |
| 硫酸头孢匹罗 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190004292 | A | 2025/02/15 | CDE ↗ |
| 头孢哌酮钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190004008 | A | 2025/03/28 | CDE ↗ |
| 头孢匹胺钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003902 | A | 2025/02/15 | CDE ↗ |
| 头孢唑林钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003889 | A | 2025/03/20 | CDE ↗ |
| 盐酸头孢吡肟 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003884 | A | 2025/03/28 | CDE ↗ |
| 头孢呋辛钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003847 | A | 2025/03/28 | CDE ↗ |
| 头孢克洛 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003846 | A | 2025/02/15 | CDE ↗ |
| 头孢曲松钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003844 | A | 2025/03/20 | CDE ↗ |
| 舒巴坦钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003843 | A | 2025/03/28 | CDE ↗ |
| 阿奇霉素 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003842 | A | 2025/06/07 | CDE ↗ |
| 头孢哌酮钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003836 | A | 2025/03/28 | CDE ↗ |
| 头孢噻吩钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003806 | A | 2025/03/20 | CDE ↗ |
| 头孢米诺钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003797 | A | 2025/06/07 | CDE ↗ |
| 头孢呋辛酯 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003796 | A | 2025/03/20 | CDE ↗ |
| 罗红霉素 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003790 | A | 2025/06/07 | CDE ↗ |
| 克拉霉素 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003787 | A | 2025/06/07 | CDE ↗ |
| 头孢噻肟钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003786 | A | 2025/03/28 | CDE ↗ |
| 头孢拉定 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20190003779 | A | 2025/03/28 | CDE ↗ |
| 头孢羟氨苄 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20170001992 | A | 2022/10/12 | CDE ↗ |
| 头孢唑肟钠 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20170000621 | I | — | CDE ↗ |
| 盐酸头孢他美酯 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20170000587 | I | — | CDE ↗ |
| 头孢丙烯 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20170000474 | I | — | CDE ↗ |
| 头孢地尼 · No verified English name | Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | Y20170000378 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
17 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 注射用头孢噻肟钠他唑巴坦钠 · No verified English name | CYHB2502405 | Supplement | 2025/11/26 | Nanjing You Ke Pharmaceutical Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢噻肟钠他唑巴坦钠 · No verified English name | CYHB2502404 | Supplement | 2025/11/26 | Nanjing You Ke Pharmaceutical Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2501979 | Supplement | 2025/10/11 | Hua Bei Pharmaceutical Group Xin Yao Research Kai Fa Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2501978 | Supplement | 2025/10/11 | Hua Bei Pharmaceutical Group Xin Yao Research Kai Fa Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2501976 | Supplement | 2025/10/11 | Hua Bei Pharmaceutical Group Xin Yao Research Kai Fa Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHS2401846 | Generic | 2024/06/21 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHS2401711 | Generic | 2024/06/07 | Nanjing Sai Rui Pu Dun Pharmaceutical Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢唑肟钠 · No verified English name | CYHS2401499 | Generic | 2024/05/18 | Nanjing En Tai Pharmaceuticals Technology Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 头孢克肟片 · No verified English name | CYHB2450064 | Supplement | 2024/01/24 | Suzhou Dawnrays Pharmaceutical Co., Ltd.; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 头孢克肟分散片 · No verified English name | CYHB2400069 | Supplement | 2024/01/09 | Hunan Ming Rui Pharmaceutical Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 头孢克肟颗粒 · No verified English name | CYHB2302116 | Supplement | 2023/09/16 | Hunan Ming Rui Pharmaceutical Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2350455 | Supplement | 2023/05/24 | Suzhou Dawnrays Pharmaceutical Co., Ltd.; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 头孢克肟颗粒 · No verified English name | CYHB2202031 | Supplement | 2022/11/05 | Hunan Ming Rui Pharmaceutical Co., Ltd. romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢拉定 · No verified English name | CYHB2201066 | Supplement | 2022/06/30 | NORTH CHINA PHARMACEUTICAL COMPANY.LTD; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| 注射用头孢拉定 · No verified English name | CYHB2201065 | Supplement | 2022/06/30 | NORTH CHINA PHARMACEUTICAL COMPANY.LTD; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2201061 | Supplement | 2022/06/30 | NORTH CHINA PHARMACEUTICAL COMPANY.LTD; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2150755 | Supplement | 2021/07/26 | Li Zhu Group Li Zhu Pharmaceutical Factory romanized; Ncpc Hebei Huamin Pharmaceutical Co. Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.